LEDERCORT FORTE 40mg/ml price in UAE

Overview

Welcome to Dwaey, specifically on LEDERCORT FORTE 40mg/ml Injection page.
This medicine contains an important and useful components, as it consists of Triamcinolone acetate.
LEDERCORT FORTE 40mg/ml is available in the market in concentration 40mg/ml and in the form of Injection.

LEDERLE LABORATORIESDIVISION, AMERICAN CYANAMID COMPANY is the producer of LEDERCORT FORTE 40mg/ml and it is imported from USA, The most popular alternatives of LEDERCORT FORTE 40mg/ml are listed downward .

Mode Of Action

Triamcinolone has mainly glucocorticoid activity. It suppresses the migration of polymorphonuclear leukocytes and reduces capillary permeability thereby decreasing inflammation.

Indication

Allergic and inflammatory responses
Inflammatory joint disease
Inflammatory skin conditions

Precaution

Diabetes; hypertension, renal and liver impairment; glaucoma; psychosis; delayed tissue healing; cirrhosis; heart failure; recent MI; hypothyroidism; osteoporosis; peptic ulceration; thromboembolic disorders. Monitor height in children on prolonged therapy. Avoid rapid drug withdrawal. Elderly, children, pregnancy, lactation. Lactation: Excreted in breast milk; use caution

Side Effects

HPA axis supression
intracranial hypertension
Cushing's syndrome
growth retardation in children; osteoporosis
fractures. Peptic ulceration; glaucoma; hyperglycaemia; GI upsets; increased appetite; increased fragility of skin; behavioural changes. Potentially Fatal: Acute adrenal insufficiency may be precipitated by infection or trauma in patients on long-term corticosteroid therapy or rapid withdrawal.

Contra indication

Triamcinolone Acetonide is contraindicated in patients with a sensitivity to the active or inactive ingredients. Untreated systemic fungal, bacterial, viral or parasitic infection, hypersensitivity. Neonates (Parenteral)

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

Lowering of plasma salicylates levels. Increased risk of GI bleeding and ulceration with NSAIDs. Antagonised blood glucose-lowering effects of the antidiabetics. Increased risk of hyperkalaemia with amphotericin B, beta agonists, beta-blockers, potassium-depleting diuretics, theophylline. Increased clearance of the triamcinolone with ciclosporin, carbamazepine, phenytoin, barbiturate, rifampicin. Infections may develop if given with live vaccines.